Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.004 AUD | 0.00% | 0.00% | +14.29% |
Mar. 25 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
Mar. 14 | Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+14.29% | 8.32M | |
+0.40% | 42.86B | |
+11.68% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.60% | 25.15B | |
-24.24% | 18.63B | |
+27.58% | 12.37B | |
-3.15% | 11.92B | |
+7.07% | 11.21B |
- Stock Market
- Equities
- AVE Stock
- News Avecho Biotechnology Limited
- Avecho Biotechnology Validates Efficacy of CBD Topical Gel Product in Hand Osteoarthritis Study; Shares Jump 8%